Related Experiment Videos
Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P
R Björkman1, K M Hallman, J Hedner
1Department of Pharmacology, University of Gothenburg and Sahlgren's Hospital, GothenburgSweden Department of Clinical Pharmacology, University of Gothenburg and Sahlgren's Hospital, GothenburgSweden.
Pain
|June 1, 1994
Summary
Acetaminophen (paracetamol) may relieve pain by inhibiting the L-arginine-nitric oxide pathway in the central nervous system. This pathway interaction, potentially involving NMDA and substance P, contributes to acetaminophen's analgesic effects.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Acetaminophen (paracetamol) is a widely used analgesic.
- Its central nervous system (CNS) mechanisms of action are not fully understood.
Purpose of the Study:
- To investigate the role of the L-arginine-nitric oxide (NO) pathway in the central analgesic effects of acetaminophen.
- To explore potential interactions with NMDA and substance P pathways.
Main Methods:
- Rats were administered spinal N-methyl-D-aspartate (NMDA), AMPA, or substance P (SP) to induce specific behaviors.
- Acetaminophen's effects on these behaviors were assessed, along with reversal by L-arginine or D-arginine.
Main Results:
- Acetaminophen antagonized behaviors induced by NMDA and SP, but not AMPA.
- The analgesic effect of acetaminophen was reversed by L-arginine, but not D-arginine, indicating NO pathway involvement.
- These findings suggest acetaminophen interacts with the CNS L-arginine-NO pathway.
Conclusions:
- The L-arginine-nitric oxide pathway is a potential central mechanism for acetaminophen's analgesic action.
- Acetaminophen's interaction with NMDA and SP receptors may mediate its effects via NO inhibition.